HomeEVMN • NYSE
add
Evommune Inc
Previous close
$21.02
Day range
$21.19 - $24.15
Year range
$13.89 - $33.20
Market cap
833.10M USD
Avg Volume
956.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.72M | 38.51% |
Net income | -28.27M | -36.41% |
Net profit margin | — | — |
Earnings per share | -1.43 | — |
EBITDA | -29.39M | -39.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.20M | 107.11% |
Total assets | 224.95M | 195.77% |
Total liabilities | 19.38M | -32.04% |
Total equity | 205.57M | — |
Shares outstanding | 36.02M | — |
Price to book | 3.22 | — |
Return on assets | -48.01% | — |
Return on capital | -52.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -28.27M | -36.41% |
Cash from operations | -16.70M | 9.79% |
Cash from investing | -122.90M | -271.53% |
Cash from financing | 156.85M | 215.58% |
Net change in cash | 17.25M | 1,012.11% |
Free cash flow | -5.15M | — |
About
Founded
2020
Headquarters
Website
Employees
48
